Cargando…
The association between acylcarnitine and amino acids profile and metabolic syndrome and its components in Iranian adults: Data from STEPs 2016
BACKGROUND: Evidence, albeit with conflicting results, has suggested that cardiometabolic risk factors, including obesity, type 2 diabetes (T2D), dyslipidemia, and hypertension, are highly associated with changes in metabolic signature, especially plasma amino acids and acylcarnitines levels. Here,...
Autores principales: | Taghizadeh, Hananeh, Emamgholipour, Solaleh, Hosseinkhani, Shaghayegh, Arjmand, Babak, Rezaei, Negar, Dilmaghani-Marand, Arezou, Ghasemi, Erfan, Panahi, Nekoo, Dehghanbanadaki, Hojat, Ghodssi-Ghassemabadi, Robabeh, Najjar, Niloufar, Asadi, Mojgan, khoshniat, Mohsen, Larijani, Bagher, Razi, Farideh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008865/ https://www.ncbi.nlm.nih.gov/pubmed/36923214 http://dx.doi.org/10.3389/fendo.2023.1058952 |
Ejemplares similares
-
Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC–MS/MS technique
por: Hosseinkhani, Shaghayegh, et al.
Publicado: (2022) -
Association of plasma acylcarnitines and amino acids with hypertension: A nationwide metabolomics study
por: Arjmand, Babak, et al.
Publicado: (2023) -
Metabolic signatures of insulin resistance in non-diabetic individuals
por: Arjmand, Babak, et al.
Publicado: (2022) -
Circulating amino acids and acylcarnitines correlated with different CAC score ranges in diabetic postmenopausal women using LC–MS/MS based metabolomics approach
por: Hosseinkhani, Shaghayegh, et al.
Publicado: (2022) -
Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2023)